Phase 1 Study of EGFR-Antisense DNA, Cetuximab, and Radiotherapy in Head and Neck Cancer With Preclinical Correlatives

BACKGROUND: Cetuximab combined with radiation therapy (RT) is an evidence-based treatment for locally advanced head and neck squamous cell carcinoma (HNSCC); however, locoregional failure remains the primary cause of cancer-related death in this disease. Intratumoral injection of epidermal growth fa...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer
Päätekijät: Bauman, Julie E., Duvvuri, Umamaheswar, Thomas, Sufi, Gooding, William E., Clump, David A., Karlovits, Brian, Wehbe, Ahmad, Miller, Frank R., Kim, Seungwon, Sen, Malabika, Heron, Dwight E., Grandis, Jennifer R., Argiris, Athanassios
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2018
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6521720/
https://ncbi.nlm.nih.gov/pubmed/30291796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.31651
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia